Corvidia Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.1B

  • Investors
  • 1

Corvidia Therapeutics General Information

Description

Developer of next-generation precision cardiovascular therapies designed to harness the power of intersections. The company's cardiovascular therapies aid to identify patients with a unique sensitivity to specific biologic pathways that focuses on the research, development and commercialization of transformative therapies for cardio-renal diseases, enabling medical providers to offer rapid development of therapies targeting those pathways.

Contact Information

Website
www.corvidiatx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 35 Gatehouse Drive
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Novo Nordisk
Vertical(s)
Life Sciences
Corporate Office
  • 35 Gatehouse Drive
  • Waltham, MA 02451
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Corvidia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 11-Jun-2020 $2.1B Completed Generating Revenue
4. Early Stage VC 24-Mar-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 25-Apr-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Feb-2016 $31.8M $31.8M Completed Startup
1. Seed Round 01-Jan-2015 Completed Startup
To view Corvidia Therapeutics’s complete valuation and funding history, request access »

Corvidia Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Corvidia Therapeutics’s complete cap table history, request access »

Corvidia Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next-generation precision cardiovascular therapies designed to harness the power of intersections. The comp
Biotechnology
Waltham, MA
4 As of 2016

San Diego, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Corvidia Therapeutics Competitors (51)

One of Corvidia Therapeutics’s 51 competitors is Sorrento Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Qrons Corporation New York, NY
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
DalCor Pharmaceuticals Venture Capital-Backed Montreal, Canada
Cellaïon Venture Capital-Backed Mont-Saint-Guibert, Belgium
You’re viewing 5 of 51 competitors. Get the full list »

Corvidia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corvidia Therapeutics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
Apple Tree Partners (ATP) Venture Capital Minority
AstraZeneca Corporation Minority
Cormorant Asset Management PE/Buyout Minority
Fresenius Medical Care Ventures Corporate Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Corvidia Therapeutics FAQs

  • When was Corvidia Therapeutics founded?

    Corvidia Therapeutics was founded in 2015.

  • Where is Corvidia Therapeutics headquartered?

    Corvidia Therapeutics is headquartered in Waltham, MA.

  • What is the size of Corvidia Therapeutics?

    Corvidia Therapeutics has 4 total employees.

  • What industry is Corvidia Therapeutics in?

    Corvidia Therapeutics’s primary industry is Biotechnology.

  • Is Corvidia Therapeutics a private or public company?

    Corvidia Therapeutics is a Private company.

  • What is the current valuation of Corvidia Therapeutics?

    The current valuation of Corvidia Therapeutics is .

  • What is Corvidia Therapeutics’s current revenue?

    The current revenue for Corvidia Therapeutics is .

  • How much funding has Corvidia Therapeutics raised over time?

    Corvidia Therapeutics has raised $91.8M.

  • Who are Corvidia Therapeutics’s investors?

    Andera Partners, Apple Tree Partners (ATP), AstraZeneca, Cormorant Asset Management, and Fresenius Medical Care Ventures are 5 of 10 investors who have invested in Corvidia Therapeutics.

  • Who are Corvidia Therapeutics’s competitors?

    Sorrento Therapeutics, Qrons, CytomX Therapeutics, DalCor Pharmaceuticals, and Cellaïon are some of the 51 competitors of Corvidia Therapeutics.

  • When was Corvidia Therapeutics acquired?

    Corvidia Therapeutics was acquired on 11-Jun-2020.

  • Who acquired Corvidia Therapeutics?

    Corvidia Therapeutics was acquired by Novo Nordisk.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »